Doyle PD

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (2)

Title : Design and synthesis of m1-selective muscarinic agonists: (R)-(-)-(Z)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-(3'-methoxyphenyl)-2-propynyl)oxime maleate (CI-1017), a functionally m1-selective muscarinic agonist - Tecle_1998_J.Med.Chem_41_2524
Author(s) : Tecle H , Barrett SD , Lauffer DJ , Augelli-Szafran C , Brann MR , Callahan MJ , Caprathe BW , Davis RE , Doyle PD , Eubanks D , Lipiniski W , Mirzadegan T , Moos WH , Moreland DW , Nelson CB , Pavia MR , Raby C , Schwarz RD , Spencer CJ , Thomas AJ , Jaen JC
Ref : Journal of Medicinal Chemistry , 41 :2524 , 1998
Abstract : Tecle_1998_J.Med.Chem_41_2524
ESTHER : Tecle_1998_J.Med.Chem_41_2524
PubMedSearch : Tecle_1998_J.Med.Chem_41_2524
PubMedID: 9651157

Title : Cholinergic therapies for Alzheimer's disease. Palliative or disease altering? - Davis_1995_Arzneimittelforschung_45_425
Author(s) : Davis RE , Doyle PD , Carroll RT , Emmerling MR , Jaen J
Ref : Arzneimittelforschung , 45 :425 , 1995
Abstract : Davis_1995_Arzneimittelforschung_45_425
ESTHER : Davis_1995_Arzneimittelforschung_45_425
PubMedSearch : Davis_1995_Arzneimittelforschung_45_425
PubMedID: 7763338